Search

Your search keyword '"Kunadt, Desiree"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Kunadt, Desiree" Remove constraint Author: "Kunadt, Desiree"
40 results on '"Kunadt, Desiree"'

Search Results

1. Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT

2. Biallelic TET2 mutation sensitizes to 5’-azacitidine in acute myeloid leukemia

4. Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

5. Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party

6. Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy

8. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

9. Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

10. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

11. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

14. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

16. Germline variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy

17. P554: RESULTS OF A RANDOMIZED PLACEBO-CONTROLLED PHASE 2 STUDY OF HYPOMETHYLATING AGENTS WITH OR WITHOUT ELTROMBOPAG IN ELDERLY AML PATIENTS (DELTA)

18. Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

20. Biallelic TET2 mutations confer sensitivity to 5'-azacitidine in acute myeloid leukemia.

21. Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia

22. Fascia training in patients undergoing allogeneic hematopoietic cell transplantation—a pilot study

23. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

24. sj-docx-1-tah-10.1177_20406207221115005 – Supplemental material for Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation

25. Additional file 1 of Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

26. Additional file 1 of Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

27. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (vol 13, 2, 2022)

28. Spatial heterogeneity and differential treatment response of acute myeloid leukemia and relapsed/refractory extramedullary disease after allogeneic hematopoietic cell transplantation

29. Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

30. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

31. Biallelic TET2 mutation sensitizes to 5’-azacitidine in acute myeloid leukemia

32. Impact of KMT2A-PTD Mutational Subgroups on Outcome of AML Patients after Induction Therapy and Allogeneic Hematopoietic Cell Transplantation

34. Unrelated Donors below 35 Years of Age Should be Preferred over HLA-Matched Sibling Donors Older Than 50 Years for Patients with Myeloid Malignancies

35. Haploidentical transplantation in primary refractory/relapsed secondary versus de novoAML: from the ALWP/EBMT

37. Multidrug-Related Protein 1 (MRP1) Polymorphisms rs129081, rs212090, and rs212091 Predict Survival In Acute Myeloid Leukemia

38. Differential impact of IDH1/2mutational subclasses on outcome in adult AML: Results from a large multicenter study

40. Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party.

Catalog

Books, media, physical & digital resources